Epizyme CFO Jason Rhodes Resigns

By RTT News, 
A A A


(RTTNews.com) - Epizyme Inc ( EPZM ), a clinical stage biopharmaceutical company focusing on genetically defined cancers, said Tuesday its Chief Financial Officer Jason Rhodes would resign from the company, effective September 30. Rhodes will be joining a venture capital firm.

The company has a search underway to identify a new CFO, and Rhodes has agreed to assist Epizyme in an advisory capacity through the end of 2014 to ensure a smooth transition.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com



This article appears in: News Headlines

Referenced Stocks: EPZM

RTT News


More from RTT News:

Related Videos

Stocks

Referenced

Most Active by Volume

106,679,460
  • $17.03 ▲ 0.47%
101,357,777
  • $38.65 ▼ 5.57%
61,830,117
  • $89.89 ▼ 4.26%
54,116,071
  • $5.11 ▼ 4.49%
50,121,934
  • $101.06 ▲ 0.10%
49,993,927
  • $3.52 ▼ 1.40%
47,717,687
  • $11.44 ▼ 4.67%
44,793,169
  • $99.05 ▼ 0.93%
As of 9/22/2014, 04:15 PM